98%
921
2 minutes
20
Serogroup B Neisseria meningitidis (MenB) is a major cause of severe sepsis and invasive meningococcal disease, which is associated with 5-15% mortality and devastating long-term sequelae. Neisserial adhesin A (NadA), a trimeric autotransporter adhesin (TAA) that acts in adhesion to and invasion of host epithelial cells, is one of the three antigens discovered by genome mining that are part of the MenB vaccine that recently was approved by the European Medicines Agency. Here we present the crystal structure of NadA variant 5 at 2 Å resolution and transmission electron microscopy data for NadA variant 3 that is present in the vaccine. The two variants show similar overall topology with a novel TAA fold predominantly composed of trimeric coiled-coils with three protruding wing-like structures that create an unusual N-terminal head domain. Detailed mapping of the binding site of a bactericidal antibody by hydrogen/deuterium exchange MS shows that a protective conformational epitope is located in the head of NadA. These results provide information that is important for elucidating the biological function and vaccine efficacy of NadA.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260552 | PMC |
http://dx.doi.org/10.1073/pnas.1419686111 | DOI Listing |
FASEB Bioadv
September 2025
Kobilka Institute of Innovative Drug Discovery, School of Medicine The Chinese University of Hong Kong Shenzhen Guangdong China.
Formyl peptide receptor 1 (FPR1) is a G protein-coupled receptor (GPCR) that mediates chemotaxis and bactericidal activities in phagocytes. The monoclonal antibody 5F1 is generated against full-length FPR1 and used widely for detection of FPR1 expression. This study aimed to characterize 5F1 for its functions.
View Article and Find Full Text PDFFront Immunol
September 2025
Clinical Immunology Department, Pasteur Institute of Tunis, Tunis, Tunisia.
Introduction: Anti-neutrophil cytoplasmic antibodies (ANCAs) have been reported in systemic lupus erythematosus (SLE). Their clinical significance remains unclear especially in the African populations. This study aimed to assess the prevalence, antigenic targets, and clinical correlations of ANCAs in SLE patients in a Tunisian (North African) cohort.
View Article and Find Full Text PDFEBioMedicine
September 2025
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Background: Invasive non-typhoid Salmonella (iNTS) is a leading cause of morbidity and mortality in sub-Saharan Africa. We assess the safety and immunogenicity of an outer membrane vesicle vaccine (iNTS-GMMA) derived from the two most common serovars, S. Enteritidis (SEn) and S.
View Article and Find Full Text PDFTalanta
September 2025
National Key Laboratory of Synthetic Biotechnology, Tianjin University, Yaguan Road 135, Jinnan District, Tianjin, 300350, PR China; School of Synthetic Biology and Biomanufacturing, Tianjin University, Yaguan Road 135, Jinnan District, Tianjin, 300350, PR China. Electronic address:
Due to their bacteriostatic or bactericidal effects, antibiotics are widely used in the prevention and treatment of human and animal diseases. However, their irrational utilization has caused severe environmental pollution and threatened human health and safety through food chain. Given the critical limitations of traditional antibiotic detection methods, such as high costs, technical complexity, and time-consuming operations, it is essential to develop robust, accurate, sensitive, and field-deployable technologies for antibiotic detection.
View Article and Find Full Text PDFVaccine
August 2025
Vaccine Evaluation Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK.; Meningococcal Reference Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK.
Background/objectives: Cases of Invasive Meningococcal Disease (IMD) dropped sharply due to non-pharmaceutical interventions during the Covid-19 pandemic, raising the possibility of a disease rebound due to an immunity gap. This has been investigated via a seroprevalence study of individuals less than 25 years old, by measuring meningococcal serogroup B (MenB) serum bactericidal antibody (SBA) titres in sera collected during 2019, 2020 and 2021. SBA titres in vaccine-eligible populations since the introduction of 4CMenB were also evaluated via comparison with data obtained before vaccine introduction.
View Article and Find Full Text PDF